← brief for 2026-11-04 · Slowing decline

Longitudinal Changes in Renal, Glycemic, Metabolic, Hematological, and Inflammatory Parameters in Patients with Diabetic Kidney Disease Treated with Empagliflozin or Dapagliflozin: A 12-Month Real-World Cohort Study

Preprint C Not peer reviewed Observational

Key takeaways

This study followed 452 people with diabetic kidney disease for 12 months. They took a diabetes drug called empagliflozin or dapagliflozin. The study looked at how their kidney and blood markers changed. It is a preprint, so it has not passed peer review yet.

Who did this work

Bennur Esen · Damla Yıldız · Khalida Baraki · Ahmet Engin Atay

Source

Preprint · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-11-03
https://doi.org/10.20944/preprints202611.0230.v1